Exact Mass: 442.3559

DG(8:0/15:0/0:0)

C26H50O5 (442.3658)

DG(8:0/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/15:0)

C26H50O5 (442.3658)

DG(8:0/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/i-15:0/0:0)

C26H50O5 (442.3658)

DG(8:0/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/i-15:0)

C26H50O5 (442.3658)

DG(8:0/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/a-15:0/0:0)

C26H50O5 (442.3658)

DG(8:0/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/a-15:0)

C26H50O5 (442.3658)

DG(8:0/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/13:0/0:0)

C26H50O5 (442.3658)

DG(10:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/13:0)

C26H50O5 (442.3658)

DG(10:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/i-13:0/0:0)

C26H50O5 (442.3658)

DG(10:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/i-13:0)

C26H50O5 (442.3658)

DG(10:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/a-13:0/0:0)

C26H50O5 (442.3658)

DG(10:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/a-13:0)

C26H50O5 (442.3658)

DG(10:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/10:0/0:0)

C26H50O5 (442.3658)

DG(13:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/10:0)

C26H50O5 (442.3658)

DG(13:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/10:0/0:0)

C26H50O5 (442.3658)

DG(i-13:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/10:0)

C26H50O5 (442.3658)

DG(i-13:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/10:0/0:0)

C26H50O5 (442.3658)

DG(a-13:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/10:0)

C26H50O5 (442.3658)

DG(a-13:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(15:0/8:0/0:0)

C26H50O5 (442.3658)

DG(15:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/8:0)

C26H50O5 (442.3658)

DG(15:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/8:0/0:0)

C26H50O5 (442.3658)

DG(i-15:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/8:0)

C26H50O5 (442.3658)

DG(i-15:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/8:0/0:0)

C26H50O5 (442.3658)

DG(a-15:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/8:0)

C26H50O5 (442.3658)

DG(a-15:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Salignarine C

C28H46N2O2 (442.3559)

Salignarine B

C28H46N2O2 (442.3559)

(20S)-20-(N,N-dimethylamino)-3beta-(N-senecoylamino)-5alpha-pregn-16-en-4beta-ol|hookerianamide J

C28H46N2O2 (442.3559)

soalnopubamine A

C28H46N2O2 (442.3559)

Solacasine

C28H46N2O2 (442.3559)

caavuranamide

C28H46N2O2 (442.3559)

(2E,20S)-20-(dimethylamino)-2beta-hydroxy-3beta-(tigloylamino)pregn-14-ene|2-hydroxysalignamine-E|2-hydroxysalignarine-E

C28H46N2O2 (442.3559)

Solacasin

C28H46N2O2 (442.3559)

N-Formylcyclovirobuxeine B

C28H46N2O2 (442.3559)

Vaganine B

C28H46N2O2 (442.3559)

Stearoyl Serotonin

C28H46N2O2 (442.3559)

SA-5HT

C28H46N2O2 (442.3559)

Hookerianamide J

C28H46N2O2 (442.3559)

A steroid alkaloid that is 5alpha-preg-16-ene substituted by a hydroxy group at position 4, a N,N-dimethylamino group at position 20 and a N-senecoylamino group at position 3 (the 3beta,4beta,20S stereoisomer). Isolated from Sarcococca hookeriana, it exhibits antileishmanial and antibacterial activities.

N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]octadecanamide

C28H46N2O2 (442.3559)

[3-Carboxy-2-(3-oxooctadecanoyloxy)propyl]-trimethylazanium

C25H48NO5+ (442.3532)

[3-carboxy-2-[(Z)-3-hydroxyoctadec-9-enoyl]oxypropyl]-trimethylazanium

C25H48NO5+ (442.3532)

[(2R)-3-carboxy-2-[(Z,3R)-3-hydroxyoctadec-11-enoyl]oxypropyl]-trimethylazanium

C25H48NO5+ (442.3532)

[(2R)-3-carboxy-2-[(Z,3R)-3-hydroxyoctadec-9-enoyl]oxypropyl]-trimethylazanium

C25H48NO5+ (442.3532)

[3-carboxy-2-[(E)-9-hydroxyoctadec-12-enoyl]oxypropyl]-trimethylazanium

C25H48NO5+ (442.3532)

[3-carboxy-2-[(E)-10-hydroxyoctadec-12-enoyl]oxypropyl]-trimethylazanium

C25H48NO5+ (442.3532)

[3-carboxy-2-[(E)-12-hydroxyoctadec-9-enoyl]oxypropyl]-trimethylazanium

C25H48NO5+ (442.3532)

[(E)-2-(carboxymethyl)-2,20-dihydroxy-3-oxoicos-4-enyl]-trimethylazanium

C25H48NO5+ (442.3532)

[(1S)-3-carboxy-1-[(Z)-3-hydroxyoctadec-11-enoyl]oxypropyl]-trimethylazanium

C25H48NO5+ (442.3532)

[(1S)-3-carboxy-1-[(Z)-3-hydroxyoctadec-9-enoyl]oxypropyl]-trimethylazanium

C25H48NO5+ (442.3532)

(1-Heptanoyloxy-3-hydroxypropan-2-yl) hexadecanoate

C26H50O5 (442.3658)

(1-Hydroxy-3-nonanoyloxypropan-2-yl) tetradecanoate

C26H50O5 (442.3658)

(1-Decanoyloxy-3-hydroxypropan-2-yl) tridecanoate

C26H50O5 (442.3658)

(1-Hydroxy-3-undecanoyloxypropan-2-yl) dodecanoate

C26H50O5 (442.3658)

(1-Butanoyloxy-3-hydroxypropan-2-yl) nonadecanoate

C26H50O5 (442.3658)

(1-Hydroxy-3-propanoyloxypropan-2-yl) icosanoate

C26H50O5 (442.3658)

(1-Hydroxy-3-octanoyloxypropan-2-yl) pentadecanoate

C26H50O5 (442.3658)

(1-Hydroxy-3-pentanoyloxypropan-2-yl) octadecanoate

C26H50O5 (442.3658)

(1-Acetyloxy-3-hydroxypropan-2-yl) henicosanoate

C26H50O5 (442.3658)

(1-Hexanoyloxy-3-hydroxypropan-2-yl) heptadecanoate

C26H50O5 (442.3658)

[(2S)-3-hydroxy-2-undecanoyloxypropyl] dodecanoate

C26H50O5 (442.3658)

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] dodecanoate

C26H50O5 (442.3658)

DG 10:0_13:0

C26H50O5 (442.3658)

DG 11:0_12:0

C26H50O5 (442.3658)

DG 23:0

C26H50O5 (442.3658)

n-{1-[1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-3-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)

n-{18-hydroxy-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²²]tetracosan-7-yl}carboximidic acid

C28H46N2O2 (442.3559)

n-{1-[1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-3-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)

(2e)-n-[(1s,3as,3bs,6r,7s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-2-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)

3-[(3-hydroxydecanoyl)oxy]hexadecanoic acid

C26H50O5 (442.3658)

n-[(3as,3br,5ar,6r,7s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)

(2e)-n-[(1s,3as,3bs,7r,8s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-2-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)

n-[(1s,2r,5s,7s,10s,11s,14s,15r,16s,17r,18s,20s,23s)-18-hydroxy-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²²]tetracosan-7-yl]carboximidic acid

C28H46N2O2 (442.3559)

n-{1-[1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-2-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)

(2e)-n-[(1s,3as,3bs,7r,8s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-2-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)

n-[(1s,3as,3bs,7r,8s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)

n-{1-[1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-2-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)

(1s,6s,8r,14r,21s)-8,21-dimethyl-10,23-diazapentacyclo[17.7.1.1⁶,¹⁰.0²³,²⁷.0¹⁴,²⁸]octacosane-7,20-dione

C28H46N2O2 (442.3559)